Zydus Lifesciences Ltd. NSE: ZYDUSLIFE | BSE: 532321

Strong Performer, Getting Expensive

Download real time

1013.85 1.90 (0.19%)

27.53% Gain from 52W Low

2.0M

NSE+BSE Volume

NSE 05 Sep, 2025 3:31 PM (IST)

Licensing Agreement

Zydus Life's arm enters a licensing agreement with Synthon BV to market Ozanimod capsules in the US See details

Zydus Lifesciences Ltd. share price target

Zydus Lifesciences Ltd. has an average share price target of 1045.33. The consensus estimate represents an upside of 3.10% from the last price of 1013.85. View 13 reports from 6 analysts offering long-term price targets for Zydus Lifesciences Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Load latest Google or static link led you to an intermediate page.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	06 Sep 2025	Zydus Lifesciences	Consensus Share Price Target	1013.85	1006.63	-	-0.71	hold	pdf Detailed Estimates
	04 Feb 2023	Zydus Lifesciences	ICICI Direct Reco Target	1013.85	500.00	434.65 (133.26%)	Target met	Buy	pdf post cache		Broker Report Zydus Life Sciences ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	02 Jan 2023	Zydus Lifesciences	Ashika Research	1013.85	480.00	420.10 (141.34%)	Target met	Buy	pdf post cache		Broker Report Ashika - Stock Picks Zydus Lifesciences Ltd. - January 2023 Ashika Research pdf Copy Link Share on Share on Share on Share on Alert
	14 Nov 2022	Zydus Lifesciences	ICICI Direct Target	1013.85	480.00	423.80 (139.23%)	Target met	Hold	pdf post cache		Broker Report Zydus Life Sciences ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	14 Nov 2022	Zydus Lifesciences	Prabhudas Lilladhar Reco Target	1013.85	465.00	416.75 (143.28%)	Target met	Accumulate	pdf post cache		Broker Report ZYDUS LIFESCIENCES L Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	14 Nov 2022	Zydus Lifesciences	ICICI Securities Limited Target	1013.85	448.00	423.80 (139.23%)	Target met	Hold	pdf post cache		Broker Report Moraiya cleared; Revlimid launched ICICI Securities Limited Zydus Lifesciences (Zydus) reported Q2FY23 performance is broadly in line with our estimates. Revenue grew 7.3% YoY to Rs40.0bn (I-Sec: Rs40.0bn) on the back of India and US markets. pdf Copy Link Share on Share on Share on Share on Alert
	12 Nov 2022	Zydus Lifesciences	Motilal Oswal Reco Target	1013.85	410.00	423.80 (139.23%)	Target met	Neutral	pdf post cache		Broker Report India and US drives while Consumer Wellness and API drag earnings Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	13 Aug 2022	Zydus Lifesciences	ICICI Direct	1013.85	405.00	386.85 (162.08%)	Target met	Hold	pdf post cache		Broker Report Zydus Life Sciences ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	11 Aug 2022	Zydus Lifesciences	Prabhudas Lilladhar Target	1013.85	425.00	386.85 (162.08%)	Target met	Buy	pdf post cache		Broker Report ZYDUS LIFESCIENCES L Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	11 Aug 2022	Zydus Lifesciences	ICICI Securities Limited Target	1013.85	411.00	364.55 (178.11%)	Target met	Accumulate	pdf post cache		Broker Report Operationally weak performance ICICI Securities Limited Zydus Lifesciences (Zydus) reported tepid operational performance in Q1FY23. pdf Copy Link Share on Share on Share on Share on Alert
	31 May 2022	Zydus Lifesciences	Geojit BNP Paribas Target	1013.85	440.00	363.20 (179.14%)	Target met	Buy	pdf post cache		Broker Report ZYDUS LIFESCIENCES LIMITED Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
more loading

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Advisor Screeners